Showing results (1-10 of 565) with videos related to
Sort By:
Pageof 57
European Urology|March 20, 2023
First-line Intravesical Chemotherapy for Non-muscle-invasive Bladder Cancer: Chimera or "Ne Plus Ultra"?Louis Lenfant, Ugo Pinar, Morgan Rouprêt, et al.Current Opinion in Urology|March 7, 2020
Current status and future directions of the use of novel immunotherapeutic agents in bladder cancerLouis Lenfant, Alireza Aminsharifi, Thomas Seisen, et al.European Urology|May 1, 2020
Adjustments in the Use of Intravesical Instillations of Bacillus Calmette-Guérin for High-risk Non-muscle-invasive Bladder Cancer During the COVID-19 PandemicLouis Lenfant, Thomas Seisen, Yohann Loriot, et al.European Urology Oncology|August 16, 2023
Unleashing the Power of Artificial Intelligence and Fusion Magnetic Resonance Imaging-Targeted Biopsy: Transforming Prostate Cancer DiagnosisLouis Lenfant, Thomas Seisen, Morgan Rouprêt, et al.European Urology|February 26, 2022
Transperineal Prostate Biopsy Is the New Black: What Are the Next Targets?Louis Lenfant, Eric Barret, Morgan Rouprêt, et al.European Urology Oncology|September 25, 2021
Current Evidence and Future Perspectives in the Management of Nonmetastatic Upper Tract Urothelial CarcinomaLouis Lenfant, Alberto Breda, Evangelos Xylinas, et al.BJU International|September 25, 2020
Genetic variability in 13q33 and 9q34 is linked to aggressiveness patterns and a higher risk of progression of non-muscle-invasive bladder cancer at the time of diagnosisLouis Lenfant, Geraldine Cancel-Tassin, Stéphane Gazut, et al.Urologic Oncology|May 16, 2020
Testosterone replacement therapy (TRT) and prostate cancer: An updated systematic review with a focus on previous or active localized prostate cancerLouis Lenfant, Priscilla Leon, Géraldine Cancel-Tassin, et al.BJU International|January 31, 2024
Learning curve for fusion magnetic resonance imaging targeted prostate biopsy and three-dimensional transrectal ultrasonography segmentationLouis Lenfant, Clément Beitone, Jocelyne Troccaz, et al.Pageof 57